I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Facheris, Maurizio
44
results:
Articles (Online) X
Search for persons
X
Sorted by: Relevance
Sorted by: Year
?
1
Foslevodopa/foscarbidopa Subcutaneous Infusion Maintains Si..:
Rosebraugh, Matthew
;
Facheris, Maurizio
Neurology. 100 (2023) 17_supplement_2 - p. , 2023
Link:
https://doi.org/10.1212/..
?
2
Safety and Efficacy of 24-Hour/Day Subcutaneous Infusion of..:
Aldred, Jason
;
Bergmans, Bruno
;
Carroll, Camille
...
Neurology. 98 (2022) 18_supplement - p. , 2022
Link:
https://doi.org/10.1212/..
?
3
Comparability of Foslevodopa/Foscarbidopa Pharmacokinetics ..:
Rosebraugh, Matthew
;
Neenan, Melina
;
Facheris, Maurizio
Clinical Pharmacology in Drug Development. 12 (2022) 4 - p. 407-415 , 2022
Link:
https://doi.org/10.1002/..
?
4
Efficacy and Safety of Foslevodopa/Foscarbidopa Versus Oral..:
Facheris, Maurizio
;
Robieson, Weining
;
Fisseha, Nahome
.
Neurology. 96 (2021) 15_supplement - p. , 2021
Link:
https://doi.org/10.1212/..
?
5
Foslevodopa/foscarbidopa Subcutaneous Infusion Maintains Eq..:
Rosebraugh, Matthew
;
Stodtmann, Sven
;
Liu, Wei
.
Neurology. 96 (2021) 15_supplement - p. , 2021
Link:
https://doi.org/10.1212/..
?
6
Efficacy and safety of foslevodopa/foscarbidopa versus oral..:
Facheris, Maurizio
;
Robieson, Weining
;
Fisseha, Nahome
.
Journal of the Neurological Sciences. 429 (2021) - p. 119569 , 2021
Link:
https://doi.org/10.1016/..
?
7
Foslevodopa/foscarbidopa subcutaneous infusion maintains eq..:
Rosebraugh, Matthew
;
Stodtmann, Sven
;
Liu, Wei
.
Journal of the Neurological Sciences. 429 (2021) - p. 119570 , 2021
Link:
https://doi.org/10.1016/..
?
8
Safety and Tolerability in Parkinson's Disease Patients Tre..:
Facheris, Maurizio
;
Benesh, Janet
;
Streit, Janet
...
Neurology. 94 (2020) 15_supplement - p. , 2020
Link:
https://doi.org/10.1212/..
?
9
ABBV-951 Maintains Stable Levodopa Exposure following Subcu..:
Rosebraugh, Matthew
;
Kym, Philip
;
Liu, Wei
.
Neurology. 94 (2020) 15_supplement - p. , 2020
Link:
https://doi.org/10.1212/..
?
10
Safety and Tolerability During a 4-Week Continuous Subcutan..:
Facheris, Maurizio
;
Criswell, Susan
;
Pavasia, Nirav
...
Neurology. 94 (2020) 15_supplement - p. , 2020
Link:
https://doi.org/10.1212/..
?
11
A Novel Levodopa/Carbidopa Prodrug (ABBV-951) 24-Hour Conti..:
Rosebraugh, Matthew
;
Kym, Philip
;
Liu, Wei
..
Neurology. 92 (2019) 15_supplement - p. , 2019
Link:
https://doi.org/10.1212/..
?
12
Critical Path for Parkinson's: Catalyzing Innovation for Pa..:
Stephenson, Diane
;
Akalu, Mussie
;
Alexander, Robert
...
Neurology. 92 (2019) 15_supplement - p. , 2019
Link:
https://doi.org/10.1212/..
?
13
Improvement in Attention/Memory Domains in Advanced Parkins..:
Standaert, David
;
Rodriguez, Ramon
;
Slevin, John
...
Neurology. 90 (2018) 15_supplement - p. , 2018
Link:
https://doi.org/10.1212/..
?
14
Rationale and Design of an Open-Label, Randomized, 26-Week ..:
Chaudhuri, K. Ray
;
Weintraub, Daniel
;
Antonini, Angelo
...
Neurology. 90 (2018) 15_supplement - p. , 2018
Link:
https://doi.org/10.1212/..
?
15
The prodromal phase of leucine-rich repeat kinase 2-associa..:
Pont-Sunyer, Claustre
;
Tolosa, Eduardo
;
Caspell-Garcia, Chelsea
...
Movement Disorders. 32 (2017) 5 - p. 726-738 , 2017
Link:
https://doi.org/10.1002/..
1-15